Calithera Biosciences, Inc. Profile Avatar - Palmy Investing

Calithera Biosciences, Inc.

Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company…

Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Calithera Biosciences, Inc. has no acquisition track records yet.

M&A Deals · History

Calithera Biosciences, Inc. has no acquisition track records yet.

M&A Deals · Within Industry

Keep an eye on latest M&A deals done inside the None Industry.

Details
UMB Financial Corporation
Equity
Agg. Maximum Price
$1,926,470,000.00
Details
?
Equity
Agg. Maximum Price
$997,170,962.65
Details
?
Equity
Agg. Maximum Price
$1,590,231,912.00
Details
?
Equity
Agg. Maximum Price
$25,679,772.00
Details
?
Equity
Agg. Maximum Price
$n/a
?
Details
?
Equity
Agg. Maximum Price
$16,662,212.53
Details
?
Equity
Agg. Maximum Price
$48,186,704.00
?
Details
First Advantage Corporation
Equity
Agg. Maximum Price
$318,310,423.50
Details
?
Equity
Agg. Maximum Price
$78,285,358.86
Details
?
Common
Agg. Maximum Price
$15,519,353.00

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
Details
?
Equity
Agg. Maximum Price
$n/a
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
End of CALA's Analysis
CIK: 1496671 CUSIP: 13089P101 ISIN: US13089P5070 LEI: - UEI: -
Secondary Listings
CALA has no secondary listings inside our databases.